BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  ReShape Lifesciences to Host Third Quarter Conference Call on November 14, 2017

  ReShape Lifesciences today announced that it will host a conference call to discuss financial results for the third quarter of 2017 on Tuesday, November 14, 2017 at 1:30 PM Pacific Time.

  October 31, 2017

   · 

  1 min read
• Business

  Cumberland Pharmaceuticals to Announce Third Quarter 2017 Financial Results

  A conference call and live Internet webcast will be held on Tuesday, November 7, 2017, at 4:30 p.m. Eastern Time to discuss the results.

  October 31, 2017

   · 

  2 min read
• 

  FDA

  Luminex Receives FDA Clearance for ARIES Group A Strep Assay

  This is the sixth assay the FDA has cleared for use on Luminex’s ARIES Systems in the last 24 months.

  October 31, 2017

   · 

  6 min read
• Biotech Bay

  Eiger BioPharma Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriter’s Option to Purchase Additional Shares

  The offering was made under the company’s effective shelf registration statement and resulted in net proceeds to the company of approximately $19.5M, after underwriting discounts and commissions and estimated offering expenses.

  October 31, 2017

   · 

  2 min read
• Business

  Regulus to Provide Third Quarter 2017 Financial Results on November 7, 2017

  Regulus will host a conference call and webcast on November 7, 2017 at 5:00 p.m. Eastern Time to discuss third quarter 2017 financial results and corporate highlights.

  October 31, 2017

   · 

  3 min read
• Drug Development

  PerkinElmer Release: Phase II Clinical Trial Data Establishes Effectiveness of Using A Child’s Own Cord Blood to Treat Cerebral Palsy

  The research from a Phase II clinical trial indicates that patients with CP who were treated with an infusion of an adequate dose of their own cord blood, which had been collected and stored at birth, saw a significant improvement in their motor function.

  October 31, 2017

   · 

  4 min read
• Business

  Masimo Reports Third Quarter 2017 Financial Results

  The Company’s worldwide direct product revenue in the third quarter of 2017 increased by $21.7 million compared to the same period in 2016 and represented 87.7% of product revenue.

  October 31, 2017

   · 

  12 min read
• Business

  Senseonics Holdings Reports Third Quarter 2017 Financial Results

  Revenue was $2.1 million for the third quarter of 2017, compared to $37,000 for the third quarter of 2016.

  October 31, 2017

   · 

  7 min read
• Business

  Dr. Markus Enzelberger Appointed MorphoSys’s Chief Scientific Officer

  He will succeed Dr. Marlies Sproll, who has been on temporary leave from her CSO position for family reasons since April 15, 2017.

  October 31, 2017

   · 

  3 min read
• Pharm Country

  Lupus Research Alliance LuCIN Clinical Trials Network Launches Inaugural Studies

  The Lupus Research Alliance today announced the first clinical trials to be conducted through its LuCIN aimed at discovering new treatments for the millions of people around the globe living with lupus.

  October 31, 2017

   · 

  4 min read